Literature DB >> 19261430

A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour.

C Pilgrim1, Val Usatoff, Peter M Evans.   

Abstract

AIMS: Surgery for gallbladder carcinoma is a technically challenging exercise. The extent of resection varies based on a number of factors, and controversy exists regarding what constitutes an acceptable resection. A review of current recommendations and practice was undertaken.
METHODS: A comprehensive literature review was performed, searching Medline for articles published since 2000, using the MeSH heading of 'gallbladder cancer' and 'surgery'. Abstracts were reviewed and articles retrieved if the main focus of the article centred on the surgical management of gallbladder carcinoma. OBSERVATIONS: The extent of hepatic resection and lymph node dissection required varies in particular with T stage. Growth pattern and anatomical location of the tumour within the gallbladder also influence surgical management.
CONCLUSIONS: Discrepancy exists between the Eastern and Western literature in terms of what constitutes an acceptable limit of resection, and these issues are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19261430     DOI: 10.1016/j.ejso.2009.02.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

Review 1.  Key factors influencing prognosis in relation to gallbladder cancer.

Authors:  Charles Henry Caldow Pilgrim; Ryan T Groeschl; Kiran K Turaga; T Clark Gamblin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

2.  Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions.

Authors:  Keita Kai; Naohiko Kohya; Kenji Kitahara; Masanori Masuda; Atsushi Miyoshi; Takao Ide; Osamu Tokunaga; Kohji Miyazaki; Hirokazu Noshiro
Journal:  Virchows Arch       Date:  2011-07-22       Impact factor: 4.064

Review 3.  Gallbladder cancer: Clinical and pathological approach.

Authors:  Keita Kai; Shinichi Aishima; Kohji Miyazaki
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

4.  Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer.

Authors:  Sung Ha Lee; Jae Do Yang; Hong Pil Hwang; Hee Chul Yu; Baik Hwan Cho
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-05-31

5.  Evaluation of a prospective surgical strategy of extended resection to achieve R0 status in gall bladder cancer.

Authors:  Biju Pottakkat; Abhimanyu Kapoor; Anand Prakash; Rajneesh Kumar Singh; Anu Behari; Ashok Kumar; Vinay K Kapoor; Rajan Saxena
Journal:  J Gastrointest Cancer       Date:  2013-03

6.  Prognosis of incidental gallbladder carcinoma is not influenced by the primary access technique: analysis of 837 incidental gallbladder carcinomas in the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

Review 7.  Gallbladder Cancer in the 21st Century.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Shahid Ahmed; Selliah Chandra Kanthan
Journal:  J Oncol       Date:  2015-09-01       Impact factor: 4.375

Review 8.  Gallbladder cancer: epidemiology and outcome.

Authors:  Rajveer Hundal; Eldon A Shaffer
Journal:  Clin Epidemiol       Date:  2014-03-07       Impact factor: 4.790

9.  Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.

Authors:  Xin-wei Yang; Jue Yang; Liang Li; Xiao-bo Man; Bao-hua Zhang; Feng Shen; Meng-chao Wu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor.

Authors:  Keita Kai; Masanori Masuda; Takao Ide; Yukari Takase; Atsushi Miyoshi; Kenji Kitahara; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Mol Clin Oncol       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.